Skip to main content

The Center for Vaccine Development and Global Health's current bi-annual Vaccinology course (PREV 627) begins in January, 2022. The course consists of a series of lectures on a variety of vaccinology topics including:

Special lectures address highly debated issues of current interest such as vaccine safety, public perception of vaccines, and emerging infectious diseases (e.g., Ebola and Zika). Lectures presented by experts in the field recruited from industry, academia, and government.

This course is a unique opportunity to acquire up-to-date knowledge in the field of vaccinology. A certificate of training is provided to those who attend regularly.


 

Syllabus (01/12/2023)

Vaccinology PREV 627

2023 M & W 9:00 - 10:00 @ HSF-II S431

DAY

Class

DATE

LECTURE TITLE

LECTURER

Monday

1

1/23/2023

History of Vaccination

Mike Levine (CVD, UMB)

Wednesday

2

1/25/2023

Vaccine Immunology Basics

Frank Toapanta (CVD, UMB)

Monday

3

1/30/2023

The rationale for use of clinical endpoints to evaluate the value of vaccines

Brad Gessner (Pfizer Vaccines)

Wednesday

4

2/1/2023

Vaccines and public health, legal and ethical considerations

Trudy Henson (UMB School of Law)

Monday

5

2/6/2023

Sex differences and vaccines

Sabra Klein (JHU School of Public Health)

Wednesday

6

2/8/2023

Adjuvant lecture

Alan Cross (CVD, UMB)

Monday

7

2/13/2023

mRNA vaccines current status and future

Barney Graham (Vaccine Research Center, NIAID)

Wednesday

8

2/15/2023

Reverse Vaccinology

Shannon Takala Harrison (CVD, UMB)

Monday

9

2/20/2023

Vaccine Policy: Role of the FDA (EUA)

Norman Baylor (Biologics Consulting; Former Director OVRR FDA)

Wedensday

10

2/22/2023

Vaccines and Public perception

Paul Offit (Children's Hospital of Philadelphia)

Monday

11

2/27/2023

Vaccine policy (VERPAK, ACIP, RedBook, SAGE)

Panel: K. Neuzil, J. Campbell, W. Chen (CVD, UMB)

Wednesday

12

3/1/2023

How and Why Vaccines are Made by Industry

Stanley Plotkin (CEPI; Pasteur Merieux)

Monday

13

3/6/2023

SARS CoV 2: An update and future

Panel: K. Neuzil, M. Fitzpatrick, E Hammershaim (CVD, UMB)

Wednesday

14

3/8/2023

Maternal/Neonatal Immunization

Marchand Arnaud (Université Libre de Bruxelles)

Monday

15

3/13/2023

Student Presentations

 

Wednesday

16

3/15/2023

Student Presentations

 

 

 

 

 

 

Monday

17

3/27/2023

Cholera bench-to-bedside

Wilbur Chen (CVD, UMB)

Wednesday

18

3/29/2023

Salmonella Vaccines

Matt Laurens and Sharon Tennant (CVD, UMB)

Monday

19

4/3/2023

Vaccines against diarrheal diseases

Karen Kotloff (CVD, UMB)

Wednesday

20

4/5/2023

Influenza

Justin Ortiz (CVD, UMB)

Monday

21

4/10/2023

Bacteria engineering as a vaccine platform

James Galen (CVD, UMB)

Wednesday

22

4/12/2023

Hepatitis C Vaccination

Andrea Cox (JHH)

Monday

23

4/17/2023

Vaccines against neglected parasitic diseases

Fabiano Oliveira (Vector Molecular Biology Section, NIAID)

Wednesday

24

4/19/2023

Vaccines against STI

Anne Jerse (Uniformed Services University)

Monday

25

4/24/2023

Pediatric vaccines and hesitancy

Douglas Opel (Seattle Children's Hospital)

Wednesday

26

4/26/2023

Modeling

Meagan Fitzpatrick (CVD, UMB)

Monday

27

5/1/2023

Malaria vaccines

Kirsten Lyke (CVD, UMB)

Wednesday

28

5/3/2023

Conjugate Vaccines

Rafi Simon (Pfizer Vaccines)

Monday

29

5/8/2023

Dengue Vaccines

Stephen Thomas (State University of NY)

Wednesday

30

5/10/2023

Systems vaccinology

John Tsang (Multiscale Systems Biology Section, NIAID)